Financials data is unavailable for this security.
View more
Year on year Extrawell Pharmaceutical Holdings Ltd 's revenues fell -18.57% from 72.58m to 59.10m. a gain of 129.27m to a loss of 162.95m.
| Gross margin | 48.70% |
|---|---|
| Net profit margin | -273.51% |
| Operating margin | -234.24% |
| Return on assets | -11.83% |
|---|---|
| Return on equity | -13.61% |
| Return on investment | -12.32% |
More ▼
Cash flow in HKDView more
In 2024, cash reserves at Extrawell Pharmaceutical Holdings Ltd fell by 8.79m. However, Cash Flow from Investing totalled 2.04m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 3.69m for operations while cash used for financing totalled 6.50m.
| Cash flow per share | -0.0639 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.4657 |
|---|---|
| Tangible book value per share | 0.465 |
More ▼
Balance sheet in HKDView more
| Current ratio | 3.45 |
|---|---|
| Quick ratio | 3.31 |
| Total debt/total equity | 0.1082 |
|---|---|
| Total debt/total capital | 0.0977 |
More ▼
Growth rates in HKD
SmartText is unavailable
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -254.50 |
